vs

Side-by-side financial comparison of Clarus Corp (CLAR) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $65.4M, roughly 1.3× Clarus Corp). PROCEPT BioRobotics Corp runs the higher net margin — -38.1% vs -47.8%, a 9.7% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -8.4%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -2.9%).

Clarus Corp is a global designer, manufacturer, and distributor of high-performance outdoor recreation, climbing, camping, and lifestyle products. It manages a portfolio of leading consumer brands, serving outdoor enthusiasts, professional athletes, and retail partners across North America, Europe, and the Asia-Pacific region, with a focus on innovative, durable gear for active lifestyles.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

CLAR vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.3× larger
PRCT
$83.1M
$65.4M
CLAR
Growing faster (revenue YoY)
PRCT
PRCT
+28.6% gap
PRCT
20.2%
-8.4%
CLAR
Higher net margin
PRCT
PRCT
9.7% more per $
PRCT
-38.1%
-47.8%
CLAR
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
-2.9%
CLAR

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CLAR
CLAR
PRCT
PRCT
Revenue
$65.4M
$83.1M
Net Profit
$-31.3M
$-31.6M
Gross Margin
27.7%
64.9%
Operating Margin
-59.6%
-4.1%
Net Margin
-47.8%
-38.1%
Revenue YoY
-8.4%
20.2%
Net Profit YoY
52.3%
-27.9%
EPS (diluted)
$-0.81
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLAR
CLAR
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$65.4M
$76.4M
Q3 25
$69.3M
$83.3M
Q2 25
$55.2M
$79.2M
Q1 25
$60.4M
$69.2M
Q4 24
$71.4M
$68.2M
Q3 24
$67.1M
$58.4M
Q2 24
$56.5M
$53.4M
Net Profit
CLAR
CLAR
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-31.3M
$-29.8M
Q3 25
$-1.6M
$-21.4M
Q2 25
$-8.4M
$-19.6M
Q1 25
$-5.2M
$-24.7M
Q4 24
$-65.5M
$-18.9M
Q3 24
$-3.2M
$-21.0M
Q2 24
$-5.5M
$-25.6M
Gross Margin
CLAR
CLAR
PRCT
PRCT
Q1 26
64.9%
Q4 25
27.7%
60.6%
Q3 25
35.1%
64.8%
Q2 25
35.6%
65.4%
Q1 25
34.4%
63.9%
Q4 24
33.4%
64.0%
Q3 24
35.0%
63.2%
Q2 24
36.1%
59.0%
Operating Margin
CLAR
CLAR
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-59.6%
-40.6%
Q3 25
-4.4%
-27.8%
Q2 25
-19.7%
-28.0%
Q1 25
-11.2%
-39.7%
Q4 24
-70.2%
-28.9%
Q3 24
-8.0%
-38.4%
Q2 24
-14.4%
-50.3%
Net Margin
CLAR
CLAR
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-47.8%
-39.1%
Q3 25
-2.3%
-25.7%
Q2 25
-15.3%
-24.7%
Q1 25
-8.7%
-35.8%
Q4 24
-91.8%
-27.6%
Q3 24
-4.7%
-35.9%
Q2 24
-9.7%
-48.0%
EPS (diluted)
CLAR
CLAR
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.81
$-0.54
Q3 25
$-0.04
$-0.38
Q2 25
$-0.22
$-0.35
Q1 25
$-0.14
$-0.45
Q4 24
$-1.72
$-0.34
Q3 24
$-0.08
$-0.40
Q2 24
$-0.14
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLAR
CLAR
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$36.7M
$245.6M
Total DebtLower is stronger
$0
$51.7M
Stockholders' EquityBook value
$196.4M
$347.7M
Total Assets
$249.0M
$487.1M
Debt / EquityLower = less leverage
0.00×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLAR
CLAR
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$36.7M
$286.5M
Q3 25
$29.5M
$294.3M
Q2 25
$28.5M
$302.7M
Q1 25
$41.3M
$316.2M
Q4 24
$45.4M
$333.7M
Q3 24
$36.4M
$196.8M
Q2 24
$46.2M
$214.1M
Total Debt
CLAR
CLAR
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$0
$51.6M
Q3 25
$2.0M
$51.6M
Q2 25
$1.9M
$51.5M
Q1 25
$1.9M
$51.5M
Q4 24
$1.9M
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
CLAR
CLAR
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$196.4M
$365.9M
Q3 25
$225.8M
$380.3M
Q2 25
$225.1M
$385.8M
Q1 25
$229.3M
$389.2M
Q4 24
$233.1M
$402.2M
Q3 24
$308.5M
$241.2M
Q2 24
$307.3M
$251.8M
Total Assets
CLAR
CLAR
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$249.0M
$508.1M
Q3 25
$283.1M
$511.5M
Q2 25
$286.5M
$513.1M
Q1 25
$292.8M
$519.4M
Q4 24
$294.1M
$534.0M
Q3 24
$375.3M
$374.1M
Q2 24
$369.4M
$374.4M
Debt / Equity
CLAR
CLAR
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.00×
0.14×
Q3 25
0.01×
0.14×
Q2 25
0.01×
0.13×
Q1 25
0.01×
0.13×
Q4 24
0.01×
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLAR
CLAR
PRCT
PRCT
Operating Cash FlowLast quarter
$12.5M
Free Cash FlowOCF − Capex
$11.6M
FCF MarginFCF / Revenue
17.7%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-9.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLAR
CLAR
PRCT
PRCT
Q1 26
Q4 25
$12.5M
$-10.3M
Q3 25
$-5.7M
$-6.6M
Q2 25
$-9.4M
$-15.0M
Q1 25
$-2.1M
$-17.0M
Q4 24
$16.6M
$-32.4M
Q3 24
$-8.3M
$-18.8M
Q2 24
$834.0K
$-15.7M
Free Cash Flow
CLAR
CLAR
PRCT
PRCT
Q1 26
Q4 25
$11.6M
$-12.2M
Q3 25
$-7.0M
$-9.5M
Q2 25
$-11.3M
$-17.8M
Q1 25
$-3.3M
$-18.8M
Q4 24
$14.4M
$-33.6M
Q3 24
$-9.4M
$-19.0M
Q2 24
$-744.0K
$-16.8M
FCF Margin
CLAR
CLAR
PRCT
PRCT
Q1 26
Q4 25
17.7%
-15.9%
Q3 25
-10.0%
-11.4%
Q2 25
-20.4%
-22.5%
Q1 25
-5.4%
-27.2%
Q4 24
20.1%
-49.2%
Q3 24
-14.0%
-32.6%
Q2 24
-1.3%
-31.4%
Capex Intensity
CLAR
CLAR
PRCT
PRCT
Q1 26
Q4 25
1.4%
2.4%
Q3 25
1.8%
3.4%
Q2 25
3.4%
3.5%
Q1 25
2.0%
2.7%
Q4 24
3.1%
1.7%
Q3 24
1.6%
0.4%
Q2 24
2.8%
2.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLAR
CLAR

Other$37.1M57%
Outdoor Segment$25.3M39%
Adventure Segment$3.0M5%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons